<clinical_study>
  <!-- This xml conforms to an XML Schema at:
    https://clinicaltrials.gov/ct2/html/images/info/public.xsd -->
  <required_header>
    <download_date>ClinicalTrials.gov processed this data on May 29, 2018</download_date>
    <link_text>Link to the current ClinicalTrials.gov record.</link_text>
    <url>https://clinicaltrials.gov/show/NCT03035903</url>
  </required_header>
  <id_info>
    <org_study_id>PBRC 2016-086</org_study_id>
    <nct_id>NCT03035903</nct_id>
  </id_info>
  <brief_title>Energy Cost for Holding a MedGem® Indirect Calorimeter</brief_title>
  <acronym>MEDGEM</acronym>
  <official_title>Energy Cost for Holding a MedGem® Indirect Calorimeter</official_title>
  <sponsors>
    <lead_sponsor>
      <agency>Pennington Biomedical Research Center</agency>
      <agency_class>Other</agency_class>
    </lead_sponsor>
    <collaborator>
      <agency>Weight Watchers International</agency>
      <agency_class>Industry</agency_class>
    </collaborator>
  </sponsors>
  <source>Pennington Biomedical Research Center</source>
  <oversight_info>
    <has_dmc>No</has_dmc>
    <is_fda_regulated_drug>No</is_fda_regulated_drug>
    <is_fda_regulated_device>No</is_fda_regulated_device>
  </oversight_info>
  <brief_summary>
    <textblock>
      The goal of this clinical protocol is to perform a randomized crossover study to determine
      the energy cost of holding the MedGem® device above a person's normal resting metabolic rate
      (RMR) compared to not holding the MedGem® device.
    </textblock>
  </brief_summary>
  <detailed_description>
    <textblock>
      Forty (40) subjects will be randomized to two (2) RMR measurements separated by a 40-minute
      rest (washout) period. The two RMR evaluation periods are as follows:

        1. RMR with MedGem® Indirect Calorimeter

        2. RMR without MedGem® Indirect Calorimeter

      Study recruitment will be performed at PBRC. Screening, consenting, and all study procedures
      will be performed within a single study visit at PBRC within the Inpatient Unit. All subjects
      will be introduced to the ventilated hood to determine presence of claustrophobia prior to
      enrollment (i.e., signing of the consent form).
    </textblock>
  </detailed_description>
  <overall_status>Recruiting</overall_status>
  <start_date type="Actual">February 13, 2017</start_date>
  <completion_date type="Anticipated">December 2018</completion_date>
  <primary_completion_date type="Anticipated">December 2017</primary_completion_date>
  <phase>N/A</phase>
  <study_type>Interventional</study_type>
  <has_expanded_access>No</has_expanded_access>
  <study_design_info>
    <allocation>Randomized</allocation>
    <intervention_model>Crossover Assignment</intervention_model>
    <primary_purpose>Other</primary_purpose>
    <masking>None (Open Label)</masking>
  </study_design_info>
  <primary_outcome>
    <measure>Resting Metabolic Rate (RMR)</measure>
    <time_frame>3 hours</time_frame>
    <description>Resting metabolic rate will be assessed via a DeltaTrac Metabolic Cart</description>
  </primary_outcome>
  <number_of_arms>2</number_of_arms>
  <enrollment type="Anticipated">40</enrollment>
  <condition>Resting Metabolic Rate</condition>
  <arm_group>
    <arm_group_label>Not holding, then holding the MedGem®</arm_group_label>
    <arm_group_type>Experimental</arm_group_type>
    <description>Subjects will be seated in an armless chair and have a RMR measurement taken while not holding, then holding a MedGem® Indirect Calorimeter.</description>
  </arm_group>
  <arm_group>
    <arm_group_label>Holding, then not holding the MedGem®</arm_group_label>
    <arm_group_type>Active Comparator</arm_group_type>
    <description>Subjects will be seated in an armless chair and have a RMR measurement taken holding, then not holding a MedGem® Indirect Calorimeter.</description>
  </arm_group>
  <intervention>
    <intervention_type>Device</intervention_type>
    <intervention_name>Not holding, then holding the MedGem®</intervention_name>
    <description>Subjects will have a RMR measurement taken first while not holding the MedGem®, and then while holding the MedGem®</description>
    <arm_group_label>Not holding, then holding the MedGem®</arm_group_label>
    <arm_group_label>Holding, then not holding the MedGem®</arm_group_label>
  </intervention>
  <intervention>
    <intervention_type>Device</intervention_type>
    <intervention_name>Holding, then not holding the MedGem®</intervention_name>
    <description>Subjects will have a RMR measurement taken first while holding the MedGem®, and then while not holding the MedGem®</description>
    <arm_group_label>Not holding, then holding the MedGem®</arm_group_label>
    <arm_group_label>Holding, then not holding the MedGem®</arm_group_label>
  </intervention>
  <eligibility>
    <criteria>
      <textblock>
        Inclusion Criteria:

          -  Age between 18-65 y

          -  BMI 25-40 kg/m2

        Exclusion Criteria:

          -  Diabetes mellitus

          -  Current smoker

          -  Presently on a weight loss regimen

          -  Medications: diabetes, oral steroids, blood pressure drugs, weight loss drugs

          -  Claustrophobia

          -  Pregnant or breastfeeding

          -  Congestive heart failure

          -  Chronic kidney disease

          -  Pacemaker or other metal implants
      </textblock>
    </criteria>
    <gender>All</gender>
    <minimum_age>18 Years</minimum_age>
    <maximum_age>65 Years</maximum_age>
    <healthy_volunteers>Accepts Healthy Volunteers</healthy_volunteers>
  </eligibility>
  <overall_official>
    <last_name>Eric Ravussin, PhD</last_name>
    <role>Principal Investigator</role>
    <affiliation>Pennington Biomedical Research Center</affiliation>
  </overall_official>
  <overall_contact>
    <last_name>Bella, Recruiting</last_name>
    <phone>225-763-3000</phone>
    <email>doctors@pbrc.edu</email>
  </overall_contact>
  <location>
    <facility>
      <name>Pennington Biomedical Research Center</name>
      <address>
        <city>Baton Rouge</city>
        <state>Louisiana</state>
        <zip>70808</zip>
        <country>United States</country>
      </address>
    </facility>
    <status>Recruiting</status>
    <contact>
      <last_name>Eric Ravussin, PhD</last_name>
      <phone>225-763-2602</phone>
      <email>doctors@pbrc.edu</email>
    </contact>
    <contact_backup>
      <last_name>Recruiting</last_name>
      <phone>225-763-3000</phone>
      <email>recruiters@pbrc.edu</email>
    </contact_backup>
    <investigator>
      <last_name>Kara L Marlatt, PhD</last_name>
      <role>Sub-Investigator</role>
    </investigator>
    <investigator>
      <last_name>Frank L Greenway, MD</last_name>
      <role>Sub-Investigator</role>
    </investigator>
  </location>
  <location_countries>
    <country>United States</country>
  </location_countries>
  <verification_date>April 2017</verification_date>
  <!-- For several months we've had both old and new date name tags                             -->
  <!-- Now, the old date names have been dropped.                                               -->
  <!-- The new date name replacements are:                                                      -->
  <!--     OLD (gone)                                        NEW (in use)                       -->
  <!--   lastchanged_date                         becomes   last_update_submitted               -->
  <!--   firstreceived_date                       becomes   study_first_submitted               -->
  <!--   firstreceived_results_date               becomes   results_first_submitted             -->
  <!--   firstreceived_results_disposition_date   becomes   disposition_first_submitted         -->
  <study_first_submitted>January 26, 2017</study_first_submitted>
  <study_first_submitted_qc>January 27, 2017</study_first_submitted_qc>
  <study_first_posted type="Estimate">January 30, 2017</study_first_posted>
  <last_update_submitted>April 3, 2017</last_update_submitted>
  <last_update_submitted_qc>April 3, 2017</last_update_submitted_qc>
  <last_update_posted type="Actual">April 5, 2017</last_update_posted>
  <responsible_party>
    <responsible_party_type>Principal Investigator</responsible_party_type>
    <investigator_affiliation>Pennington Biomedical Research Center</investigator_affiliation>
    <investigator_full_name>Eric Ravussin</investigator_full_name>
    <investigator_title>Associate Executive Director for Clinical Science</investigator_title>
  </responsible_party>
  <patient_data>
    <sharing_ipd>No</sharing_ipd>
    <ipd_description>The data will be not be shared outside of Weight Watchers and the Investigators listed on the protocol for this study.</ipd_description>
  </patient_data>
  <!-- Results have not yet been posted for this study                                          -->
</clinical_study>

